Business & Finance · November 5, 2026
Wendy's rejects $1.4 billion takeover proposal from Nelson Peltz’s Trian
FreeGet stories like this compared, every morning at 7.

Wendy's board of directors has unanimously rejected a $1.4 billion buyout proposal from a group led by Trian Fund Management, an investment firm founded by activist investor Nelson Peltz. The offer, which valued the company at $7.35 per share, was dismissed by the board as substantially undervaluing Wendy's standalone prospects and long-term earnings potential. To resist the take-private bid, Wendy's adopted a shareholder rights plan, commonly known as a 'poison pill'. The rejection follows Wendy's third-quarter earnings report, which showed a decline in same-restaurant sales amid inflationary pressures and high beef prices, though the company beat some Wall Street analyst expectations.
Read the original coverage
- ReutersWire
Wendy's rejects Trian-led $1.4 billion buyout offer, adopts 'poison pill' plan
Read at Reuters ↗ - ABC NewsMainstream
Wendy's rejects buyout bid from activist investor and adopts 'poison pill' plan
Read at ABC News ↗ - CBS NewsMainstream
Wendy
Read at CBS News ↗ Wendy’s Rejects Takeover Bid From Peltz's Trian
Read at Bloomberg ↗- New York PostTabloid
Wendy’s rejects $1.4B takeover bid — ‘substantially undervalues’ company, adopts ‘poison pill’ plan
Read at New York Post ↗ - Washington TimesMainstream
Wendy's rejects buyout bid from activist investor and adopts 'poison pill' plan
Read at Washington Times ↗ - CNBCMainstream
Wendy's rejects $1.4 billion takeover proposal from Nelson Peltz’s Trian
Read at CNBC ↗ - ForbesFinancial
Wendy’s Says Billionaire Peltz’ $1.4 Billion Buyout Deal ‘Substantially Undervalues’ Fast Food Chain
Read at Forbes ↗
Reported by multiple outlets
- Wendy's board of directors unanimously rejected a $1.4 billion takeover bid.
- The bid was led by Nelson Peltz's Trian Fund Management.
- The offer price was $7.35 per share.
- The board stated the proposal substantially undervalues the company's future prospects.
- Wendy's reported third-quarter U.S. same-restaurant sales decreased compared to the previous year.
- Wendy's adopted a 'poison pill' shareholder rights plan.
Reported by only some outlets
- Trian Fund Management already owns 16% of Wendy's.
- The bidder group includes Flynn Group LP, BlueFive Capital, and Sixth Street Partners.
- Bob Wright joined Wendy's as CEO in May.
- The 'poison pill' plan allows shareholders to purchase shares at a discount if an individual's ownership exceeds 15%.
- Trian previously made a hostile takeover attempt of Wendy's in 2022.
- Third-quarter revenue was $547 million, down from $549.5 million in the prior year.
- Wendy's stock rose more than 2% following the earnings report.
Industry-friendly coverage frames it as…
Most coverage focuses on Wendy's 'turnaround strategy', long-term 'earnings potential', and the board's confidence in the standalone plan under new leadership.
Skeptical / consumer coverage frames it as…
Several outlets highlight Wendy's status as a 'struggling' chain, noting its 'slumping' stock price and the challenges of high beef prices and aging stores.
FreeDaily Brief newsletter
Get the 5-minute Daily Brief, with the topics you pick.
The Daily Brief is free
About these outlets
CadNews does not determine absolute truth or endorse political viewpoints. It compares publicly available reporting, identifies shared facts, highlights framing differences, and flags uncertainty.
